Position in ELAN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$383,286
+$20,890 QoQ
Shares Held
16,017
+0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Claret Asset Management Corp holds $23,258,930 across 6 Drug Manufacturers - Specialty & Generic names. ELAN ranks #3 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
707,267 | $21,557,498 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
806 | $477,941 | |
| 3 | ELAN |
Elanco Animal Health Inc
This page
|
16,017 | $383,286 | |
| 4 | VTRS |
Viatris Inc
|
26,710 | $360,852 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
1,923 | $253,336 | |
| 6 | ZTS |
Zoetis Inc.
|
1,912 | $226,017 |
All Filings in ELAN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $383,286 | 16,017 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $362,396 | 16,014 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $323,287 | 16,052 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $232,492 | 16,281 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $114,838 | 10,937 | Principal | Sole | 2025-05-13 | |
| 2024-12-31 | $132,350 | 10,929 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $159,430 | 10,853 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $155,786 | 10,796 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||